文献速递胸部CT

系列定量胸部CT评估COVID-19:深度学习方法

Serial Quantitative Chest CT Assessment of COVID-19: A Deep Learning Approach.
PubMed 文献 · Radiol Cardiothorac Imaging · 2020-03-30

该研究回顾性纳入126例COVID-19患者,按基线临床、实验室和CT表现分为轻型、中型、重型、危重型,使用商业深度学习软件自动量化全肺及五个肺叶的CT磨玻璃影百分比。结果显示基线全肺磨玻璃影百分比在四组间有显著差异(P<.01),从基线到第一次随访显著增加(中位数3.6% vs 8.7%,P<.01),第一次到第二次随访无显著进展(8.7% vs 6.0%,P=.655)。

要点

  • 深度学习可自动量化COVID-19全肺及肺叶磨玻璃影百分比,减少主观评估差异。
  • 基线磨玻璃影百分比在轻型至危重型间逐渐升高,各组间差异显著(P<.01)。
  • 全肺磨玻璃影百分比从基线到第一次随访显著增加(中位数3.6% vs 8.7%,P<.01)。

核心结论

  • 深度学习工具定量COVID-19胸部CT磨玻璃影百分比在不同临床严重程度组间存在显著差异。
  • 该方法可能消除COVID-19肺部表现初始评估和随访中的主观性。

研究设计与样本

  • 回顾性研究,纳入2020年1月1日至2月3日期间接受胸部CT的126例COVID-19患者(平均年龄52岁±15,53.2%男性)。
  • 根据基线临床、实验室和CT表现将患者分为轻型(6例)、中型(94例)、重型(20例)和危重型(6例)。
  • 使用商业深度学习软件自动量化全肺及五个肺叶的CT磨玻璃影百分比,并与随访CT比较。

关键影像表现/征象

  • CT磨玻璃影百分比在基线的不同临床分组间有显著差异,从轻型到危重型逐渐进展(所有P<.01)。
  • 全肺磨玻璃影百分比从基线CT到第一次随访CT显著增加(中位数[四分位距]:3.6%[0.5%, 12.1%] vs 8.7%[2.7%, 21.2%];P<.01)。
  • 从第一次随访到第二次随访CT,磨玻璃影百分比无显著进展(8.7%[2.7%, 21.2%] vs 6.0%[1.9%, 24.3%];P=.655)。

诊断标准与关键数值

  • 全肺磨玻璃影百分比由商业深度学习软件自动量化,基线值在轻型至危重型组间逐渐升高(所有P<.01)。
  • 全肺磨玻璃影百分比从基线到第一次随访中位数由3.6%升至8.7%(P<.01)。
  • 全肺磨玻璃影百分比从第一次到第二次随访中位数由8.7%降至6.0%,无显著差异(P=.655)。

临床应用与阅片要点

  • 深度学习自动定量磨玻璃影百分比可用于COVID-19患者肺部受累程度的客观评估和随访比较。
  • 阅片时可关注全肺及肺叶磨玻璃影百分比的动态变化,辅助判断病情进展。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To quantitatively evaluate lung burden changes in patients with coronavirus disease 2019 (COVID-19) by using serial CT scan by an automated deep learning method.

MATERIALS AND METHODS: Patients with COVID-19, who underwent chest CT between January 1 and February 3, 2020, were retrospectively evaluated. The patients were divided into mild, moderate, severe, and critical types, according to their baseline clinical, laboratory, and CT findings. CT lung opacification percentages of the whole lung and five lobes were automatically quantified by a commercial deep learning software and compared with those at follow-up CT scans. Longitudinal changes of the CT quantitative parameter were also compared among the four clinical types.

RESULTS: A total of 126 patients with COVID-19 (mean age, 52 years ± 15 [standard deviation]; 53.2% males) were evaluated, including six mild, 94 moderate, 20 severe, and six critical cases. CT-derived opacification percentage was significantly different among clinical groups at baseline, gradually progressing from mild to critical type (all P < .01). Overall, the whole-lung opacification percentage significantly increased from baseline CT to first follow-up CT (median [interquartile range]: 3.6% [0.5%, 12.1%] vs 8.7% [2.7%, 21.2%]; P < .01). No significant progression of the opacification percentages was noted from the first follow-up to second follow-up CT (8.7% [2.7%, 21.2%] vs 6.0% [1.9%, 24.3%]; P = .655).

CONCLUSION: The quantification of lung opacification in COVID-19 measured at chest CT by using a commercially available deep learning-based tool was significantly different among groups with different clinical severity. This approach could potentially eliminate the subjectivity in the initial assessment and follow-up of pulmonary findings in COVID-19.Supplemental material is available for this article.© RSNA, 2020.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Huang L, Han R, Ai T, et al. Serial Quantitative Chest CT Assessment of COVID-19: A Deep Learning Approach. Radiol Cardiothorac Imaging. 2020. PMID: 33778562. doi:10.1148/ryct.2020200075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。